How ALDH2 affects mouth and esophagus cell health and cancer
Official title: Aldh2 and epithelial homeostasis and pathobiology
Funded at Columbia University Health Sciences · NIH-11381708 · Data updated 2026-11-12
Researchers are testing ways to block alcohol-related damage in mouth and esophagus cells so treatments can better target aggressive squamous cell cancers.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | July 1, 2018 |
| Project end | March 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $370,125 |
| NIH project number | 5R01AA026297-09 |
| Project ID | NIH-11381708 on NIH RePORTER |
Who could benefit from this research
✓Could help
People with or at high risk for head-and-neck or esophageal squamous cell carcinoma—especially those with heavy alcohol use or known ALDH2 dysfunction—would be the most relevant candidates for related trials or tissue-donation efforts.
✕Less likely to help
Patients with cancers that are not squamous cell types of the head, neck, or esophagus, or those whose disease is unrelated to alcohol/ALDH2 biology, are less likely to benefit from this specific line of research.
What this research studies
From a patient point of view, the team studies how the enzyme ALDH2 and alcohol byproducts (like acetaldehyde) damage cells in the mouth and esophagus and help dangerous cancer cells survive. They grow miniature patient- and mouse-derived organoids (tiny tissue models) to watch how DNA damage and a survival marker called CD44 let cancer cells resist chemotherapy and alcohol stress. The researchers use genetic tools and drugs that block a repair protein (FANCT) to see if cancer organoids die while normal tissue survives. The work seeks drug targets that could one day lead to treatments that kill cancer cells linked to alcohol exposure without harming healthy tissue.
Why it matters
Potential benefit: If successful, this could lead to therapies that more precisely kill alcohol-related head-and-neck and esophageal squamous cancers while sparing normal tissue.
How similar studies have gone: Early laboratory and organoid studies show promising results for targeting the Fanconi anemia pathway in these cancers, but clinical benefit in patients has not yet been established.
Where this research is happening
-
Columbia University Health Sciences
New York, United States Active
Researchers
- Principal investigator: Nakagawa, Hiroshi — Columbia University Health Sciences
- Study coordinator: Nakagawa, Hiroshi
Related research
Other NIH-funded projects on the same topics.
-
Precision phenotyping of emphysema in the elderly: a study in diverse adults
Researchers will look at CT scans and lung tests in older adults to understand different forms of emphysema and how they relate to health outcomes.
-
HPV-based cervical cancer screening and treatment implementation in resource-limited settings
A collaborative project to help doctors in South Africa put HPV-based screening and same-day treatment for cervical cancer into routine care, so more people get fast, effective care.
-
Cervical cancer screening and treatment rollout in resource-poor settings
A team from Columbia and the University of Cape Town is testing how to best implement affordable, same-day HPV-based screen-and-treat for cervical cancer in public health settings.
-
Understanding SCN3A-related Developmental Epileptic Encephalopathy and Finding Better Treatments
This NIH grant focuses on how SCN3A gene variants cause developmental epileptic encephalopathy and aims to develop more effective therapies for affected patients.
-
mChoice: Boosting PrEP Use and Adherence for Black and Latino MSM with Tailored Training and Support
A national study to help Black and Latino men who have sex with men start and stick with PrEP through culturally matched provider training and patient support.
-
M-CaRE: Mobile clinics and a smart heart-lung care tool for multimorbidity
A mobile, multilingual tool plus community health workers will help screen and manage high blood pressure and COPD in diverse adult patients, especially in underserved areas.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.